NORTHERN CLINICS OF ISTANBUL, cilt.7, sa.4, ss.321-328, 2020 (ESCI, TRDizin)
OBJECTIVE: In this study, we evaluated the influences of BRAF(V600E) mutation on clinicopathological features in incidentally found papillary thyroid microcarcinomas (PTMCs).